Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases
Irmler A, Bechthold E, Davioud-Charvet E, Hofmann V, Rau R, et al
Glutathione Deep cellular protection for clients describing toxin exposure, inflammatory stress, or heavy medication/alcohol burden
The incidence of renal dysfunction is related to the severity of the acetaminophen ingestion * : Patients with liver involvement but no hepatic failure: ~5% Patients with severe poisoning:10% Patients with acute hepatic failure: ~50% Pathogenesis * Direct toxicity by toxic metabolites of APAP, oxidized by CYP in the kidney
A promising clinical trial of women with endometriosis showed decreased diameter and volume, decreased number, and even disappearance of endometriotic lesions after treatment for 3 months with NAC (168)
